Spacelabs Healthcare Launches Enhanced Flow Meter Visualization

ISSAQUAH, Wash.--()--Spacelabs Healthcare announced today that it has received FDA 510k clearance for Enhanced Flow Meter Visualization on its BleaseSirius Anesthesia System.

Identifying key information quickly and easily is critical to the anesthesia delivery practice and the ability to record and retrieve this data is also increasingly important. With traditional flow control for the Electronic Gas Flow Measurements, clinicians retain the current “touch & feel” they are accustomed to. The exact digital readout for each individual gas is displayed using 3D flow tubes and numerics, making for an easy to read format. Furthermore, the dedicated display is positioned where clinicians would find traditional flow tubes, allowing them to instantly know the fresh gas flow to their patient. This data is immediately available for export to a patient monitoring system or electronic medical record.

“Spacelabs Anesthesia Systems, including the new BleaseSirius, incorporate the latest technology offering clinicians unparalleled performance in ventilation and vaporization,” said Nicholas Ong, Group President, Spacelabs Healthcare. “Focusing on the patient and clinician to machine relationship has allowed us to offer clinicians integrated technology, reduced cost of ownership and clinical ease of use.”

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s BleaseSirius product. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.

Contacts

Spacelabs Healthcare
Lee Dalgety, 425-657-7200 x4010
Lee.Dalgety@Spacelabs.com

Contacts

Spacelabs Healthcare
Lee Dalgety, 425-657-7200 x4010
Lee.Dalgety@Spacelabs.com